Navigation Links
Head-to-Head Study Demonstrates Focalin(R) XR Offers Faster and Better Symptom Control than Concerta(R)1 in Early Part of ADHD Patients' Day
Date:7/8/2008

part of a total treatment program for ADHD that may include other measures (e.g., psychological, educational, social) for patients with this syndrome.

Important Safety Information

The most common adverse events seen with Focalin XR were dyspepsia, decreased appetite, headache and anxiety in pediatric studies; and dry mouth, dyspepsia, feeling jittery, dizziness, headache and anxiety in adult studies.

Focalin XR is contraindicated in patients with marked anxiety, tension and agitation since the drug may aggravate these symptoms; in patients known to be hypersensitive to methylphenidate or other components of the product; in patients with glaucoma; in patients with motor tics or with a family history or diagnosis of Tourette's syndrome; and during or following treatment with monoamine oxidase inhibitors.

Stimulants should generally not be used in children, adolescents or adults with known serious structural cardiac abnormalities, cardiomyopathy, serious heart-rhythm abnormalities or other serious cardiac problems. Use with caution in treating patients with underlying medical conditions that might be compromised by increases in blood pressure or heart rate, such as those with pre-existing hypertension, heart failure, recent myocardial infarction or ventricular arrhythmia. Before initiating treatment, patients should have careful history and physical exam to assess for presence of cardiac disease.

Use with caution in psychosis or bipolar disorder. Discontinuation of treatment may be appropriate in the presence of treatment-emergent psychotic or manic symptoms. While aggressive behavior is often observed in children or adolescents with ADHD, patients beginning treatment should be monitored for the appearance of or worsening of aggressive behavior or hostility.

Suppression of growth has been reported with long-term use of stimulants. Stimulants should be used with caution in patients with a prior history of seizures or EEG abnorm
'/>"/>

SOURCE Novartis Pharmaceuticals Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Two-Year Outcomes From Large Head-to-Head Clinical Trial Indicate Similar Safety Profile in Diabetic Patients for Cypher(R) Sirolimus-Eluting Coronary Stent and Taxus Stent
2. Cleveland Clinic to Lead First Head-to-Head Comparison of the Two Most Potent Statins
3. New Data From Head-to-Head Study Confirms Once-Daily Levemir(R) is as Effective as Glargine over a 24-Hour Period in Subjects with Type 2 Diabetes
4. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
5. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
6. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
7. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
8. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
9. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
10. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... SAN FRANCISCO , July 2, 2015  The ... www.tryloud.com ), the world,s first HIPAA compliant mobile app ... delivery of farm-to-table fresh medical marijuana, announced today that ... Unlike Eaze, Meadow and more than half ... in the last year, Loud Cannabis is unique in ...
(Date:7/2/2015)... , July 2, 2015 ... (Homofermentative & Heterofermentative), Species (Lactobacillus, Pediococcus & Enterococcus), Enzymes ... and Forecast to 2020", Silage Inoculants & Enzymes Market ... a CAGR of 4.0% from 2015 to 2020. ... igures spread through 194 P ...
(Date:7/2/2015)... , July 2, 2015  The Commission ... agreement with ASHP, an organization that represents pharmacists ... a provider of continuing education for recertification of ... track of geriatric programs for this purpose.  ASHP ... as authorized providers for the CCGP Professional Development ...
Breaking Medicine Technology:New Cannabis Delivery App Gets Product to Patient in Under 7 Minutes 2Silage Inoculants & Enzymes Market Worth $489.05 Million by 2020 2Silage Inoculants & Enzymes Market Worth $489.05 Million by 2020 3Silage Inoculants & Enzymes Market Worth $489.05 Million by 2020 4Commission for Certification in Geriatric Pharmacy Adds ASHP as Professional Development Program Provider 2
... DUBLIN, Calif., June 16 SuperGen Inc.,(Nasdaq: ... to the discovery, rapid,development and commercialization of ... announced at the 13th Congress of the,European ... its JAK2 kinase inhibitor, prevents tumor cell ...
... COGENT-1 Study of CGT-2168 Expands to Europe; Focus ... Gastrointestinal Side Effects of Antiplatelet Therapy, ... Pharmaceuticals,Inc. today announced that the first patient has ... 3 study of its novel combination medicine,CGT-2168. The ...
Cached Medicine Technology:SuperGen's JAK2 Inhibitor, SGI-1252, Inhibits in Vivo Tumor Cell Proliferation 2European Enrollment Begins in Pivotal Phase 3 Trial of Novel Combination Medicine Developed by Cogentus Pharmaceuticals 2
(Date:7/2/2015)... ... July 02, 2015 , ... When Walker Parking ... the University of Minnesota, they knew it would save the university energy and ... award-winning choice: the total energy savings after installation was an impressive 89 percent, ...
(Date:7/2/2015)... ... 2015 , ... With summer in full swing, Americans are flocking to Canada’s many lakes to ... for fishing in the world, and it’s easy to understand why. From the Pacific Northwest ... , Recreational fishing is a huge industry, and Americans make up the vast majority ...
(Date:7/2/2015)... ... July 02, 2015 , ... “ LIFX ” was featured on ... technology products available to consumers. Amanda Forstrom, a technology expert and special reporter for ... most versatile smart light bulbs on the market. , According to the U.S. Department ...
(Date:7/2/2015)... ... July 02, 2015 , ... Get ready ... SIGVARIS PERFORMANCE SOCKS. Since the socks were first introduced, they have rapidly been ... popularity has inspired four new, fun shades including: blue, lime, pink and red. ...
(Date:7/2/2015)... , ... July 02, 2015 , ... Six months ahead ... solo cross-country walk to raise awareness and money for the Pulmonary Hypertension Association ... arrive at PHA’s headquarters near Washington, D.C. by mid-September. He left Glasgow, Mont. yesterday ...
Breaking Medicine News(10 mins):Health News:Kenall’s TekDek™ Helps University Achieve Award-Winning Energy Savings in Parking Structure Lighting Retrofit 2Health News:The Most Versatile Smart Light Bulbs were featured on NewsWatch Television 2Health News:SIGVARIS is Sporting Four Brand New Colors in the Popular PERFORMANCE SOCK Product Line 2Health News:79-Year-old ‘Pacing Parson’ Passes 1,000-Mile Mark in Cross-Country Walk for Pulmonary Hypertension Association 2Health News:79-Year-old ‘Pacing Parson’ Passes 1,000-Mile Mark in Cross-Country Walk for Pulmonary Hypertension Association 3
... to have developed a device to facilitate keyhole surgery for ... as a breakthrough in spinal treatment. // ... neurosurgery at King George's Medical University (KGMU), has developed a ... the complicated and painful procedures practised so far. ...
... XR drug for attention deficit hyperactivity disorder (ADHD) needs to ... the US FDA regulators. // ,It has ... about the side effects of the drug such as hallucinations ... with no identifiable risk factors. The FDA had prepared a ...
... was caught in the throes of a bizarre incident that threw ... whole of the ICU was held hostage by a patient’s relative. ... that his child, who was on the road to recovery, not ... ,The police was informed, but they did not react immediately. ...
... hand, foot and mouth disease (HFMD). Eight children have already ... situation the state government has worked out a series of preventive ... in five areas of the state, bringing the total number to ... to spread to the interior rural areas. Cases are seen at ...
... teenager to death. Disturbing images of this violent act were captured// ... truth, saying it was a natural death, but upon a second ... of 14, had been brutally beaten to death. This incident and ... demand in the U.S to close down all the boot camps. ...
... of AGD Impact, the newsmagazine of the Academy of ... way to correct crooked teeth. Orthodontics, the branch of ... help in improving the "stability, function, and health of ... feel better about themselves,” said AGD spokesperson James G. ...
Cached Medicine News:Health News:New Device Developed For Treating Cervical Spondylitis 2Health News:Malaysia to Beef in Medical Care to Fight against HFMD 2
Used for emergency airway access when conventional endotracheal intubation cannot be performed. Supplied sterile in peel-open packages. Intended for one-time use....
... Standard/Conventional Blade. Stainless Steel. Lamp supplied ... tradition of high quality standard incandescent ... blades have been continually refined through ... over to minimize maintenance requirements. They ...
... Rusch Snap-Light™ laryngoscope blades are designed ... diameter fiber optic bundle can be removed ... hard to reach areas. Our unique snap-on ... The bright focused blades are interchangeable with ...
... Greenspec Laryngoscopes are a high quality ... of bringing greater standardization to fiberoptic laryngoscopes. ... fiberoptic and indicates it's ability to interconnect ... Fiberoptic light offers a cool, bright and ...
Medicine Products: